Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue BMC Cancer Année : 2012

Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.

Michèle Sabbah
Gérard Redeuilh
  • Fonction : Auteur
  • PersonId : 931604
Monique Bedin
  • Fonction : Auteur
  • PersonId : 931605
Jan Mester
  • Fonction : Auteur
  • PersonId : 931606

Résumé

UNLABELLED: ABSTRACT: BACKGROUND: Ligand-dependent activation of the estrogen receptor (ER) as well as of the insulin-like growth factor type 1 (IGF1R) induces the proliferation of luminal breast cancer cells. These two pathways cooperate and are interdependent. We addressed the question of the mechanisms of crosstalk between the ER and IGF1R. METHODS: We evaluated the mitogenic effects of estradiol (E2; agonist ligand of ER) and of insulin (a ligand of IGF1R) in the MCF-7 cells by flow cytometry and by analyzing the cell levels of cell cycle-related proteins (immunoblotting) and mRNA (RT-QPCR). To verify the requirement for the kinase activity of Akt (a downstream target of IGF1R) in the mitogenic action of estradiol, we used shRNA strategy and shRNA-resistant expression vectors. RESULTS: The activation of the ER by E2 is unable to induce the cell cycle progression when the phosphatidyl inositol-3 kinase (PI3K)/Akt signaling is blocked by a chemical inhibitor (LY 294002) or by shRNA targeting Akt1 and Akt2. shRNA-resistant Akt wild-type constructs efficiently complemented the mitogenic signaling activity of E2 whereas constructs with inactivated kinase function did not. In growth factor-starved cells, the residual PI3K/Akt activity is sufficient to complement the mitogenic action of E2. Conversely, when ER function is blocked by the antiestrogen ICI 182780, IGF1R signaling is intact but does not lead to efficient reinitiation of the cell cycle in quiescent, growth factor-starved MCF-7 cells. The basal transcription-promoting activity of ligand-free ER in growth factor-starved cells is sufficient to complement the mitogenic action of the IGF1R-dependent signaling. CONCLUSIONS: The basal ER activity in the absence of ligand is sufficient to allow efficient mitogenic action of IGF1R agonists and needs to be blocked to prevent the cell cycle progression.

Domaines

Cancer
Fichier principal
Vignette du fichier
1471-2407-12-291.pdf (493.85 Ko) Télécharger le fichier
1471-2407-12-291-S1.PPT (77 Ko) Télécharger le fichier
1471-2407-12-291-S2.PPT (114.5 Ko) Télécharger le fichier
1471-2407-12-291-S3.PPT (100.5 Ko) Télécharger le fichier
1471-2407-12-291-S4.PPT (196 Ko) Télécharger le fichier
1471-2407-12-291-S5.PPT (297 Ko) Télécharger le fichier
1471-2407-12-291.xml (85.44 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Loading...

Dates et versions

inserm-00743408 , version 1 (18-10-2012)

Identifiants

Citer

Anne-Marie Gaben, Michèle Sabbah, Gérard Redeuilh, Monique Bedin, Jan Mester. Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.. BMC Cancer, 2012, 12 (1), pp.291. ⟨10.1186/1471-2407-12-291⟩. ⟨inserm-00743408⟩
174 Consultations
311 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More